M O'Brien
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Neurology top 10%
- Neuroblastoma Research and Treatments
- CNS Lymphoma Diagnosis and Treatment
Papers in
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 1
- Co-authors
- Frank M. BalisPeter C. AdamsonGregory H. ReamanBrigitte C. WidemannSusan M. BlaneyRobert F. MurphyElizabeth FoxMichael Montello
- Journals
- Journal of Clinical Oncology (5 papers)Pediatric Blood & Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Journal of the American Chemical Society (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
M O'Brien
11 papers receiving 527 citations
Peers
Comparison fields: 5 of 67
- Hematology 118
- Neurology 115
- Public Health, Environmental and Occupational Health 195
- Genetics 58
- Biochemistry 29
Countries citing papers authored by M O'Brien
This map shows the geographic impact of M O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M O'Brien more than expected).
Fields of papers citing papers by M O'Brien
This network shows the impact of papers produced by M O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M O'Brien. The network helps show where M O'Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside M O'Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2010 | 106 | |
| 3 | 2007 | 91 | |
| 4 | 2006 | 35 | |
| 5 | 2004 | 39 | |
| 6 | Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. | 1999 | 43 |
| 7 | 1999 | 1 | |
| 8 | 1998 | 13 | |
| 9 | 1997 | 96 | |
| 10 | 1997 | 51 | |
| 11 | 1997 | 50 | |
| 12 | A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. | 1997 | 17 |
About M O'Brien
M O'Brien is a scholar working on Transplantation, Hematology, Dermatology, Neurology and Public Health, Environmental and Occupational Health, having authored 12 papers that have together received 542 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Neuroblastoma Research and Treatments (4 papers), Retinoids in leukemia and cellular processes (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chemotherapy-related skin toxicity (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Treatment and Pharmacology (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (118 citations), Neurology (115 citations), Public Health, Environmental and Occupational Health (195 citations), Genetics (58 citations) and Biochemistry (29 citations). M O'Brien has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Frank M. Balis, Peter C. Adamson, Gregory H. Reaman, Brigitte C. Widemann, Susan M. Blaney, Robert F. Murphy, Elizabeth Fox, Michael Montello, John M. Sorensen and Stacey L. Berg. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, JNCI Journal of the National Cancer Institute, Journal of the American Chemical Society and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.